Health News Releases

  • Today January 24
December 08, 2025 15:12
Galderma Welcomes Increased Equity Investment From L’Oréal
Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that L’Oréal Groupe intends to increase its equity investment in the company, acquiring an additional 10% stake
IDE034, a Bispecific ADC Licensed by Biocytogen to IDEAYA, Receives FDA IND Clearance
December 05, 2025 17:15
IDE034, a Bispecific ADC Licensed by Biocytogen to IDEAYA, Receives FDA IND Clearance
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), announced that its partner IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision oncology company, has received the clearance o
December 05, 2025 15:40
Galderma Opens up New Chapter for Sculptra® with MDR Certification and New Expanded Indication for Body
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the certification of Sculptra for body indications in the European Union (EU) following its certification under the EU
December 05, 2025 14:15
Parse Biosciences Launches Evercode Whole Blood Fixation
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the launch of Evercode™ Whole Blood Fixation, a new kit that enables immediate fixati
Deanna Kelly, PharmD, BCPP, Live It, Launch It program lead
December 05, 2025 11:20
University of Maryland Launches Innovative Clinician Training Program in Ketogenic Metabolic Therapy for Mental Health
Baszucki Group today announced a partnership with University of Maryland School of Medicine for an innovative training initiative that will build capacity for delivering ketogenic metabolic therapy in
December 05, 2025 11:00
Famenity's Brain Factor-7® Gains Global Momentum as Clinically Validated Ingredient for Cognitive Health
Famenity Co., Ltd. (https://famenity.com/home-en/), a South Korean research and development company specializing in functional ingredients for health supplements, said that its Brain Factor-7® (BF-7®)
December 04, 2025 15:09
Galderma Secures ‘BBB’ Credit Rating With Positive Outlook from S&P Global Ratings
Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that S&P Global Ratings (S&P) has assigned the company a ‘BBB’ long-term issuer credit rating with a positive o
November 27, 2025 16:00
U.S. FDA Grants Priority Review to Sonrotoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
BeOne Medicines Ltd (https://beonemedicines.com/). (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted and
November 26, 2025 16:20
With Two in Five Employees Undergoing Fertility Treatment Leaving Their Jobs or Considering Quitting, Are Companies Doing Enough?
An international survey, spanning Australia, France, Japan, Poland and the UK, has found that many employees experiencing fertility challenges lack support in the workplace, with almost two in five (3
November 25, 2025 09:40
Merck Takes Patient-Directed Approach to Bring Innovation to the Treatment of Rare Neuromuscular Disorder, Generalized Myasthenia Gravis
Merck, a leading science and technology company, today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for cladribine capsules for the treatment of the rare, c
November 23, 2025 11:30
BeOne Medicines Showcases Leadership in B-cell Malignancies at ASH 2025
BeOne Medicines Ltd. (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fbeonemedicines.com%2F&esheet=54361159&newsitemid=20251120303213&lan=en-US&anchor=BeOne+Medicines+Ltd.&index=1&md5
Rajashekar Vasantha (left), Supreet Deshpande (center), and Sahitya Sridhar (right), the founding te
November 21, 2025 14:20
Synthio Labs Raises $5 Million to Build the Voice AI Operating System for Life Sciences Customer Engagement
Synthio Labs, a clinical-grade voice AI company transforming how life sciences organisations engage clinicians and patients, today announced that it has raised $5 million in seed funding. The round wa
The main entrance of K2 MEDITECH headquarters, representing the company’s commitment to innovation a
November 21, 2025 14:07
K2 MEDITECH Sets a New Benchmark in the Global Skin Booster Market
Built on innovative skin-regeneration technology, K2 MEDITECH is rapidly gaining attention in the global beauty and medical aesthetics industries. As a specialized manufacturer of skin boosters, th
November 20, 2025 15:10
Parse Biosciences Announces FFPE-compatible Barcoding Technology for Whole Transcriptome Single Cell Analysis
Parse Biosciences, the leading provider of scalable and accessible single cell sequencing solutions, today announced a breakthrough technology that unlocks the full potential of formalin-fixed, paraff
November 20, 2025 15:00
Positive Phase 3 Results Support ZIIHERA® as HER2-Targeted Therapy-of-Choice and Combination with TEVIMBRA® and Chemotherapy as New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma
BeOne Medicines Ltd. (https://beonemedicines.com/) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive top-line results from the Phase 3 HERIZON-GEA-01 trial e
SPARK Headquarters (SPARK HQ) (Photo: AETOSWire)
November 20, 2025 13:30
Sharjah Emerges as a Global Hub for Medical Innovation and Collaborative R&D
In the United Arab Emirates, where cities like Abu Dhabi (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fu.ae%2Fen%2Fabout-the-uae%2Fthe-seven-emirates%2FAbu-Dhabi&esheet=54359920&n
November 18, 2025 16:06
Swiss-Based Debiopharm Seeks to Boost Innovation in Japanese Cancer Research Through the New
Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company aiming to cure cancer and infectious diseases, is pleased to announce today the launch of the new IDEAL Japan initiative. This progra
November 18, 2025 15:10
Henlius and Organon Announce US FDA Approval of POHERDY® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US
Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced that the US Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for POHERDY® (pert
November 17, 2025 15:50
ASDS 2025: Compelling New Data on Restylane, Sculptra and Relfydess Highlight Galderma’s Innovative Injectable Aesthetics Portfolio and Pipeline
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it presented new data from its Injectable Aesthetics portfolio and pipeline at the American Society for Dermatolog
November 16, 2025 13:40
Stealth Third Rock Ventures Backed Company Selects Parse Biosciences GigaLab to Build Largest TCR Atlas for Common Autoimmune Disease
Third Rock Ventures and Parse Biosciences today announced a strategic collaboration to create an unprecedented atlas of 5 million T cell receptors (TCRs) using Parse Biosciences’ GigaLab platform. The
Bernard Tannoury, President of Benta SAS, and Sohail Zaidi, CEO of Ananda Scientific Inc., signing t
November 16, 2025 13:25
Ananda Scientific and Benta Sign Memorandum on Advancing Treatments for PTSD
Ananda Scientific Inc., a clinical-stage drug development company advancing innovative therapies for high-impact neuropsychiatric disorders, today announced the signing of a Memorandum of Understandin
November 14, 2025 15:10
Galderma Completes Successful Placement of CHF 175 Million Bond
NOT FOR DISTRIBUTION IN THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE RESTRICTED BY APPLICABLE LAW OR REGULATION. Galderma Group AG (SIX:GALD), the pure-play de
November 13, 2025 14:50
FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma
The U.S. Food and Drug Administration (FDA) has approved the Promega (https://bit.ly/4nUmP66) OncoMate® MSI Dx Analysis System as a companion diagnostic designed to identify patients with microsatelli
November 13, 2025 10:55
InterSystems Launches HealthShare AI Assistant to Optimize Data Retrieval and Clinical Engagement with Conversational Intelligence
InterSystems (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.intersystems.com%2F&esheet=54356186&newsitemid=20251112864064&lan=en-US&anchor=InterSystems&index=1&md5=a79330a679c0
Qorium is successfully producing sustainable real leather
November 12, 2025 16:25
Qorium Secures €22m Investment to Accelerate Cultivated Leather Commercialisation
Qorium, the Dutch biotechnology company pioneering cultivated leather, today announced it has secured a €22 million investment from Invest-NL and LIOF alongside existing investors Brightlands Venture
25 per page50 per page75 per page100 per page